The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Orion will be the exclusive partner for the distribution, marketing, and sales of Shilpa's Recombinant Human Albumin in Europe
Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables
This collaboration positions WACKER and RNAV8 as premium mRNA service providers
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
The JV will establish a state-of-the-art manufacturing facility to manufacture fermented animal free protein to cater to the global markets
Capital expenditure expected to moderate to Rs. 5.6 billion in FY2025 from an estimated Rs. 7.6 billion in FY2024
Greg was also central to the planning, design, and construction of this facility
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
Subscribe To Our Newsletter & Stay Updated
